[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 11,648
Sort by:

Metastatic Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major metastatic hepatocellular carcinoma markets are expected to exhibit a CAGR of 13.63% during 2024-2034. The metastatic hepatocellular carcinoma market has been comprehensively analyzed in I...

May 2024 135 pages

Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major metastatic HER2-positive breast cancer markets are expected to exhibit a CAGR of 1.18% during 2024-2034. The metastatic HER2-positive breast cancer market has been comprehensively analyzed...

May 2024 138 pages

Metastatic Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major metastatic melanoma markets are expected to exhibit a CAGR of 8.23% during 2024-2034. The metastatic melanoma market has been comprehensively analyzed in IMARC's new report titled 'Metasta...

May 2024 132 pages

Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major metastatic prostate cancer markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The metastatic prostate cancer market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Mild Cognitive Impairment Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mild cognitive impairment markets are expected to exhibit a CAGR of 4.02% during 2024-2034. The mild cognitive impairment market has been comprehensively analyzed in IMARC's new report tit...

May 2024 137 pages

Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major minimal residual disease markets reached a value of US$ 855.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,261.0 Million by 2034, exhibiting a growth rate (...

May 2024 138 pages

Mitochondrial Myopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mitochondrial myopathies markets reached a value of US$ 22.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Mood Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mood disorders markets reached a value of US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 1.78% d...

May 2024 128 pages

Morquio Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Morquio syndrome markets are expected to exhibit a CAGR of 4.45% during 2024-2034. The Morquio syndrome market has been comprehensively analyzed in IMARC's new report titled 'Morquio Syndr...

May 2024 134 pages

Motor Neuron Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major motor neuron disease markets reached a value of US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Mouth Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mouth neoplasms markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.0 Billion by 2034, exhibiting a growth rate (CAGR) of 3.69%...

May 2024 137 pages

Mucopolysaccharidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mucopolysaccharidoses markets are expected to exhibit a CAGR of 5.9% during 2024-2034. The mucopolysaccharidoses market has been comprehensively analyzed in IMARC's new report titled 'Muco...

May 2024 128 pages

Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The mucopolysaccharidosis market has been comprehensively analyzed in IMARC's new report titled 'Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Fore...

May 2024 138 pages

Multiple Endocrine Neoplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major multiple endocrine neoplasia markets are expected to exhibit a CAGR of 10.2% during 2024-2034. The multiple endocrine neoplasia market has been comprehensively analyzed in IMARC's new repo...

May 2024 132 pages

Multiple System Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major multiple system atrophy markets reached a value of US$ 129.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 187.2 Million by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Muscle Spasticity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major muscle spasticity markets reached a value of US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.84...

May 2024 128 pages

Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major musculoskeletal pain markets reached a value of US$ 3,975.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,399.8 Million by 2034, exhibiting a growth rate (CA...

May 2024 134 pages

Myasthenia Gravis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myasthenia gravis markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.99...

May 2024 134 pages

Mycosis Fungoides Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mycosis fungoides markets are expected to exhibit a CAGR of 4.9% during 2024-2034. The mycosis fungoides market has been comprehensively analyzed in IMARC's new report titled 'Mycosis Fung...

May 2024 129 pages

Mydriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major mydriasis markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The mydriasis market has been comprehensively analyzed in IMARC's new report titled 'Mydriasis Market: Epidemiol...

May 2024 137 pages

Myelodysplastic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myelodysplastic syndrome markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 136 pages

Myocardial Infarction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myocardial infarction markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Myocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myocarditis markets reached a value of US$ 1,373.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,281.7 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 131 pages

Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myofascial pain syndromes markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The myofascial pain syndromes market has been comprehensively analyzed in IMARC's new report tit...

May 2024 135 pages

Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myopia markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The myopia market has been comprehensively analyzed in IMARC's new report titled 'Myopia Market: Epidemiology, Indu...

May 2024 138 pages

Myotonic Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major myotonic dystrophy markets reached a value of US$ 96.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 260.4 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 139 pages

Nasal Polyps Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major nasal polyps markets reached a value of US$ 68.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 109.0 Million by 2034, exhibiting a growth rate (CAGR) of 4.3% d...

May 2024 137 pages

Nasopharyngeal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major nasopharyngeal cancer markets reached a value of US$ 858.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,075.5 Million by 2034, exhibiting a growth rate (CAG...

May 2024 128 pages

Necrotizing Enterocolitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major necrotizing enterocolitis markets reached a value of US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neonatal sepsis markets are expected to exhibit a CAGR of 7.12% during 2024-2034. The neonatal sepsis market has been comprehensively analyzed in IMARC's new report titled 'Neonatal Sepsis...

May 2024 133 pages

Netherton Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Netherton syndrome markets reached a value of US$ 21.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 69.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 132 pages

Neuroblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neuroblastoma markets reached a value of US$ 256.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 328.2 Million by 2034, exhibiting a growth rate (CAGR) of 2.28...

May 2024 130 pages

Neurocutaneous Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neurocutaneous syndromes markets are expected to exhibit a CAGR of 6.63% during 2024-2034 The neurocutaneous syndromes market has been comprehensively analyzed in IMARC's new report titled...

May 2024 138 pages

Neuroectodermal Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neuroectodermal tumors markets are expected to exhibit a CAGR of 1.07% during 2024-2034. The neuroectodermal tumors market has been comprehensively analyzed in IMARC's new report titled 'N...

May 2024 134 pages

Neuroendocrine Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neuroendocrine carcinoma markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 138 pages

Neurofibroma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neurofibroma markets are expected to exhibit a CAGR of 11.2% during 2024-2034. The neurofibroma market has been comprehensively analyzed in IMARC's new report titled 'Neurofibroma Market:...

May 2024 131 pages

Neurofibrosarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neurofibrosarcoma markets are expected to exhibit a CAGR of 9.6% during 2024-2034. The neurofibrosarcoma market has been comprehensively analyzed in IMARC's new report titled 'Neurofibrosa...

May 2024 129 pages

Neuromyelitis Optica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neuromyelitis optica markets reached a value of US$ 299.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 469.2 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 135 pages

Neuropathic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neuropathic pain markets reached a value of US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.7%...

May 2024 128 pages

Neurotrophic Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major neurotrophic keratitis markets reached a value of US$ 137.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 248.0 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 136 pages

Niemann-Pick Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Niemann-Pick disease markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The Niemann-Pick disease market has been comprehensively analyzed in IMARC's new report titled 'Niema...

May 2024 137 pages

Niemann-Pick Disease Type A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Niemann-Pick disease type A markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The Niemann-Pick disease type A market has been comprehensively analyzed in IMARC's new report...

May 2024 132 pages

Niemann-Pick Disease Type C Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Niemann-Pick disease type C markets are expected to exhibit a CAGR of 16.9% during 2024-2034. The Niemann-Pick disease type C market has been comprehensively analyzed in IMARC's new report...

May 2024 130 pages

Night Vision Disturbances Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major night vision disturbances markets reached a value of US$ 308.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 430.5 Million by 2034, exhibiting a growth rate (C...

May 2024 133 pages

Nocturia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major nocturia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 5.93% during...

May 2024 130 pages

Nocturnal Enuresis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major nocturnal enuresis markets are expected to exhibit a CAGR of 4.84% during 2024-2034. The nocturnal enuresis market has been comprehensively analyzed in IMARC's new report titled 'Nocturnal...

May 2024 131 pages

Non-alcoholic Fatty Liver Disease (NAFLD) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

 US$ 6,499.00

The 7 major Non-alcoholic fatty liver disease (NAFLD) markets reached a value of US$ 13.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.4 Million by 2034, exhibiting a...

May 2024 137 pages

Non Hodgkin’s Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Non Hodgkin’s lymphoma markets reached a value of US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Non-Small Cell Lung Cancer (NSCLC) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

 US$ 6,499.00

The 7 major non-small cell lung cancer (NSCLC) markets reached a value of US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.1 Billion by 2034, exhibiting a growth...

May 2024 130 pages

Nonmelanoma Skin Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major nonmelanoma skin cancer markets reached a value of US$ 467.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 621.3 Million by 2034, exhibiting a growth rate (CAG...

May 2024 140 pages

Filters

Clear all

Search

Categories

18
13
12
10
9
8
8
7
7
6
6
5
4
4
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
75
56
45
45
44
41
41
38
38
31
30
29
28
27
26
26
24
24
23
23
23
22
22
21
21
21
21
21
20
20
19
19
19
19
18
18
17
17
16
16
15
15
15
14
14
14
14
14
13
13
13
13
13
12
12
12
12
12
12
12
11
11
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
80
22
20
17
13
12
10
10
10
10
10
10
9
9
9
8
8
7
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
22
21
18
14
14
14
13
13
13
13
12
12
10
8
8
7
7
7
7
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
41
31
29
25
22
20
8
7
7
5
4
4
4
3
3
2
2
1
1
1
1
49
34
33
16
7
5
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
23
13
13
9
7
7
7
6
4
3
3
2
1
1
1
6
4
4
3
2
1
32
9
25
1
1,751
55
26
30
213
64
26
25
15
13
1
3
150
141
158
9
252
191
27
21
7
40
6
2
2
21
401
162
15
232
19
261
225
18
7
45
25
17
16
12

Publishers

11,648

Regions

1
1
123
22
14
11
7
5
4
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
8
3
2
1
6
3
3
2
1
1
13
11,187
5
9
19
11
2
141
13

Price

—

Date

—

Pages

—

Offers